骨髓间充质干细胞对肝癌治疗的研究现状
Current Research Status of Bone Marrow Mesenchymal Stem Cells in the Treatment of Hepatocellular Carcinoma
DOI: 10.12677/jcpm.2025.41062, PDF,   
作者: 闫 婧, 刘玉婷：济宁医学院临床医学院(附属医院)，山东 济宁；王全义*：济宁医学院附属医院病理科，山东 济宁
关键词: 干细胞；骨髓间充质干细胞；治疗；Stem Cells； Bone Mesenchymal Stem Cells； Treatment
摘要: 肝癌作为全球范围内最常见的恶性肿瘤之一，其治疗一直是医学研究的重点。近年来，干细胞研究逐渐成为热点，特别是在治疗晚期肝病领域，干细胞疗法已经取得了显著成就。然而，其在肝癌治疗领域的应用研究相对较少，其安全性问题尚需深入探究。本综述旨在探讨骨髓间充质干细胞(BMSCs)在肝癌治疗中的临床和实验研究现状。
Abstract: As one of the most common malignant tumors in the world, the treatment of liver cancer has been the focus of medical research. In recent years, stem cell research has gradually become a hot spot, especially in the treatment of advanced liver disease, stem cell therapy has made remarkable achievements. However, its application in the field of liver cancer treatment is relatively few, and its safety needs to be further explored. This review aims to investigate the clinical and experimental research status of Bone mesenchymal stem cells (BMSCs) in the treatment of liver cancer.
文章引用：闫婧, 刘玉婷, 王全义. 骨髓间充质干细胞对肝癌治疗的研究现状[J]. 临床个性化医学, 2025, 4(1): 415-421. https://doi.org/10.12677/jcpm.2025.41062

参考文献

[1] Tuan, R.S., Boland, G. and Tuli, R. (2003) Adult Mesenchymal Stem Cells and Cell-Based Tissue Engineering. Arthritis Research & Therapy, 5, Article No. 32. [Google Scholar] [CrossRef] [PubMed]
[2] Zheng, J., Xie, Y., Yoshitomi, T., Kawazoe, N., Yang, Y. and Chen, G. (2022) Stepwise Proliferation and Chondrogenic Differentiation of Mesenchymal Stem Cells in Collagen Sponges under Different Microenvironments. International Journal of Molecular Sciences, 23, Article 6406. [Google Scholar] [CrossRef] [PubMed]
[3] 尤微, 熊建义, 曹清丽, 黄俊锋. 骨髓间充质干细胞构建组织工程半月板软骨种子细胞[J]. 海南医学, 2011, 22(14): 4-7.
[4] 王连庆, 翟俏丽, 赵培庆, 李涛. 骨髓间充质干细胞分化过程中表观遗传调控机制的研究进展[J]. 生物技术通报, 2016, 32(7): 21-27.
[5] 王帅(综述), 张霄雁, 李哲海(审校). 骨髓间充质干细胞成骨细胞分化研究进展[J]. 医学综述, 2015, 21(12): 2137-2139.
[6] Yang, G., Fan, X., Liu, Y., Jie, P., Mazhar, M., Liu, Y., et al. (2023) Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem Cells. Stem Cell Reviews and Reports, 19, 1214-1231. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, Y., Liu, L., Wang, X., Shen, X., Pei, Y. and Liu, Y. (2024) Bone Marrow Mesenchymal Stem Cells Suppress Activated CD4+ T Cells Proliferation through TGF-Beta and IL10 Dependent of Autophagy in Pathological Hypoxic Microenvironment. Biochemical and Biophysical Research Communications, 702, Article 149591. [Google Scholar] [CrossRef] [PubMed]
[8] 符真, 张剑权, 李志, 周帅. BMSCs对肝癌肝切除后肝细胞再生的作用[J]. 海南医学, 2017, 28(16): 2665-2668.
[9] Qihao, Z., Xigu, C., Guanghui, C. and Weiwei, Z. (2007) Spheroid Formation and Differentiation into Hepatocyte-Like Cells of Rat Mesenchymal Stem Cell Induced by Co-Culture with Liver Cells. DNA and Cell Biology, 26, 497-503. [Google Scholar] [CrossRef] [PubMed]
[10] 张锋. 肝癌免疫耐受机制研究进展[J]. 复旦学报(医学版), 2020, 47(2): 280-287.
[11] 魏瑗, 陈东萍, 吴锐奇, 王许燕, 邝栋明. 肝细胞肝癌免疫微环境与治疗研究新进展[J]. 药学进展, 2022, 46(8): 588-602.
[12] 曾柱, 龙金华. 肝癌细胞对树突状细胞线粒体功能的抑制作用[J]. 第三军医大学学报, 2010, 32(9): 930-933.
[13] Wu, J., Ji, C., Cao, F., Lui, H., Xia, B. and Wang, L. (2017) Bone Marrow Mesenchymal Stem Cells Inhibit Dendritic Cells Differentiation and Maturation by MicroRNA-23b. Bioscience Reports, 37, BSR20160436. [Google Scholar] [CrossRef] [PubMed]
[14] Jiang, X., Liu, Z., You, H., Tang, Z., Ma, Y., Nie, R., et al. (2024) Quercetin-Primed BMSC-Derived Extracellular Vesicles Ameliorate Chronic Liver Damage through miR-136-5p and GNAS/STAT3 Signaling Pathways. International Immunopharmacology, 142, Article 113162. [Google Scholar] [CrossRef] [PubMed]
[15] Awadalla, A., Hamam, E.T., Mostafa, S.A., Mahmoud, S.A., Elazab, K.M., El Nakib, A.M., et al. (2023) Hepatoprotective Effects of Hyaluronic Acid-Preconditioned Bone Marrow Mesenchymal Stem Cells against Liver Toxicity via the Inhibition of Apoptosis and the Wnt/β-Catenin Signaling Pathway. Cells, 12, Article 1526. [Google Scholar] [CrossRef] [PubMed]
[16] 李天然, 杜湘珂, 宋斌, 魏正茂, 霍天龙. 骨髓间充质干细胞对高转移肝癌模型的干预[J]. 中国组织工程研究, 2013, 17(49): 8498-8504.
[17] 王海龙, 张良, 郭艾. 超顺磁性氧化铁纳米颗粒的理化性质及其标记BMSCs的安全性、示踪时效性研究进展[J]. 山东医药, 2015, 55(24): 99-101.